Based on its cash, cash equivalents and investments as of December 31, the company continues to expect its cash runway to fund operations into ...

Analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of BioNTech in a research report ...

After the boycott’s launch Friday, March 7, Amazon stock underwent a transient 2.12 percent dip, with shares dropping from an ...

The EC’s committee on expatriate voting rights has suggested a roadmap, which the commission approved yesterday.

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Our recently implemented re-structuring and the re-prioritization of our clinical portfolio meaningfully extends our cash runway into late ...

Officers, 10% owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the ...

Clene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at D. Boral Capital in a note issued to investors on Wednesday,Benzinga reports. They currently have ...

The company met earnings consensus and topped expectations for the fiscal first quarter. But guidance for the new quarter and ...

Even after South Korea’s Constitution Court delivers its verdict, the country’s fierce and fractured partisan divide is ...

Corrections often lead to robust recoveries, with historical returns averaging 25% in the year following severe volatility.

No matter the market environment, you’ll always find entertainment in the biotech space. There will always be biotech stocks ...